Access cutting-edge mild alzheimer's disease treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Baltimore location
Preparing your pre-screening questions…
Access mild alzheimer's disease specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related mild alzheimer's disease treatment provided free
Check if you qualify for this mild alzheimer's disease clinical trial in Baltimore, MD
No-Cost Study Care
Local to Baltimore
Convenient for MD residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The Anti-Aβ mAb CED Study is a prospective, longitudinal coverage with evidence development (CED) study using clinical data, patient assessments, and administrative claims data of the Medicare population, conducted in accordance to the National Coverage Determination (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease (AD).
Sponsor: Centers for Medicare and Medicaid Services/ Coverage and Analysis Group
Yes, this clinical trial (NCT06058234) has an active research site in Baltimore, MD that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for mild alzheimer's disease treatment options in Baltimore, MD, this clinical trial (NCT06058234) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced mild alzheimer's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all mild alzheimer's disease clinical trials near you to find additional studies recruiting in your area.
See all heart attack clinical trials recruiting in Baltimore — not just this study.
Browse Heart Attack Trials in Baltimore →